Browsing by Author Koh Chee Liang, Stephen

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 1 to 20 of 57  next >
Issue DateTitleAuthor(s)
2006A prognosis tool based on hemostasis and genetic complementary learningTan, T.Z.; Ng, G.S.; Quek, C.; Koh, S.C.L. 
1999A prospective study on the effects of reformulated 2-rod Norplant implant on haemostasis after five years of useKoh, S.C.L. ; Viegas, O.A.C. ; Ratnam, S.S. 
1995Amniotic fluid plasminogen activators and inhibitors and TAT-complex levels during 2nd trimester pregnancy and labourKoh, S.C.L. ; Anandakumar, C. ; Arulkumaran, S. ; Chua, S.E.; Yuen, W.K.; Ng, B.L. ; Ratnam, S.S. 
2000An assessment of the effects on coagulation of midtrimester and final- trimester amniotic fluid on whole blood by thrombelastograph® analysisLiu, E.H.C. ; Shailaja, S.; Lee, T.-L. ; Koh, S.C.L. 
2005An intelligent tutoring system for trauma management (Trauma-Teach): A preliminary reportOng, L.S. ; Koh, C.S. ; Lai, C.C.; Lim, C.W. ; Loke, W.F.; Low, S.H. ; Tang, K.Y.; Wong, F.L.; Yong, K.L.; Vijayan, A.
2007Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancerZhao, C.; Annamalai, L. ; Koh, S.C.L. ; Zhang, H.; Biswas, A. ; Choolani, M. ; Guo, C.; Kothandaraman, N. 
Nov-1997Coagulation Activation, Fibrinolysis and Inhibitors in NeonatesKoh, S.C.L. ; Cheong, Y.C.; Arulkumaran, S. ; Ratnam, S.S. 
2005Coagulation and fibrinolysis in preeclampsia and neonatesTanjung, M.T.; Siddik, H.D.; Hariman, H.; Koh, S.C.L. 
1999Coagulation and fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcomeKoh, S.C.L. ; Anandakumar, C. ; Biswas, A. 
1990Comparative study on the effect of Diane and Microgynon 50 contraceptive in the haemostatic mechanisms in Chinese subjectsKoh, S.C.L. ; Ratnam, S.S. ; Tsakok, F.H.M.
1992Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycleKoh, S.C.L. ; Wong, P.C.; Yuen, R.; Chua, S.E.; Ng, B.L.; Ratnam, S.S. 
2004Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.Kothandaraman, N.; Bajic, V.B.; Loganath, A. ; Koh, S. ; Ng, J.; Choolani, M. ; Razvi, K.
1992Effect of long-term use of Norplant® implants on haemostatic functionSingh, K. ; Viegas, O.A.C. ; Koh, S.C.L. ; Ratnam, S.S. 
1992Effect of Norplant®-2 rods on haemostatic functionSingh, K. ; Viegas, O.A.C. ; Koh, C.L.S. ; Ratnam, S.S. 
1989Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet functionPrasad, R.N.V. ; Koh, S. ; Ratnam, S.S. 
Jan-1999Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrelPrasad, R.N.V. ; Koh, S.C.L. ; Viegas, O.A.C.; Ratnam, S.S. 
2000Enhanced fibrinolysis and thrombin generation in ovarian cancer patients with than without metastasisKohcl, S. ; Thamk, F. ; Khalil, R. ; Oep, L.; Lim, F.K. ; Chua, S.E.; Yuen, W.K.; Ng, B.L.; Roy, A.C. ; Prasad, R.N.V. 
2001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K. ; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
2001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K.; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
2005Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycleKoh, S.C.L. ; Prasad, R.N.V. ; Fong, Y.F.